Contract

Manufacturing Execution System (MES) software for CGCT pre-GMP Advanced Therapies Digital & Automation Productivity Testbed

  • Catapult CT

F03: Contract award notice

Notice identifier: 2024/S 000-010273

Procurement identifier (OCID): ocds-h6vhtk-044e2e

Published 28 March 2024, 12:07pm



Section one: Contracting authority

one.1) Name and addresses

Catapult CT

Cell and Gene Therapy Manufacturing Centre, Gunnels Wood Road

Stevenage

SG1 2FX

Email

procurement@ct.catapult.org.uk

Country

United Kingdom

NUTS code

UKH23 - Hertfordshire

National registration number

07964711

Internet address(es)

Main address

https://ct.catapult.org.uk/

one.4) Type of the contracting authority

Body governed by public law

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Manufacturing Execution System (MES) software for CGCT pre-GMP Advanced Therapies Digital & Automation Productivity Testbed

Reference number

SEA0045

two.1.2) Main CPV code

  • 72212323 - Computer-aided manufacturing (CAM) software development services

two.1.3) Type of contract

Services

two.1.4) Short description

Provision of a Manufacturing Execution System (MES) tailored explicitly for the field of cell therapies, The MES platform should enable resource scheduling, inventory optimisation, management & execution of electronic batch records and overall manufacturing workflows, review and release activities. All workflows should be client-configurable and controlled, through the use of a zero-code, platform-embedded, builder configuration tool. The platform should be designed to comply with US FDA, EU EMA & UK MHRA guidance and aligns with the GAMP5 validation methodology, as well as being CFR 21 Part 11 compliant.

two.1.6) Information about lots

This contract is divided into lots: No

two.1.7) Total value of the procurement (excluding VAT)

Value excluding VAT: £350,000

two.2) Description

two.2.3) Place of performance

NUTS codes
  • UKH23 - Hertfordshire
Main site or place of performance

Stevenage

two.2.4) Description of the procurement

Provision of a Manufacturing Execution System (MES) tailored explicitly for the field of cell therapies, The MES platform should enable resource scheduling, inventory optimisation, management & execution of electronic batch records and overall manufacturing workflows, review and release activities. All workflows should be client-configurable and controlled, through the use of a zero-code, platform-embedded, builder configuration tool. The platform should be designed to comply with US FDA, EU EMA & UK MHRA guidance and aligns with the GAMP5 validation methodology, as well as being CFR 21 Part 11 compliant.

two.2.5) Award criteria

Price

two.2.11) Information about options

Options: No

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No


Section four. Procedure

four.1) Description

four.1.1) Type of procedure

Award of a contract without prior publication of a call for competition in the cases listed below

  • The services can be provided only by a particular economic operator for the following reason:
    • protection of exclusive rights, including intellectual property rights

Explanation:

The provision of services involved are purely for the purpose of research, experimentation, study or development, Autolomous have developed a Manufacturing Execution System tailored explicitly for the field of cell therapies. Unlike other MES solutions repurposed from different sectors, Autolomous? offering is designed from the ground up to meet the unique challenges and complexities inherent in cell therapy manufacturing processes. Autolomous? aim is to democratise access to life-altering treatments, making them universally available, economically viable, and logistically feasible.

Central to this software suite is the autoloMATE platform. The MES platform enables resource scheduling, inventory optimisation, management & execution of electronic batch records and overall manufacturing workflows, review and release activities. All workflows are client-configurable and controlled, through the use of a zero-code, platform-embedded, builder configuration tool. The autoloMATE platform has been designed to comply with US FDA, EU EMA & UK MHRA guidance and aligns with the GAMP5 validation methodology, as well as being CFR 21 Part 11 compliant.

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes


Section five. Award of contract

Contract No

SEA0045

Title

Manufacturing Execution System (MES) software for CGCT pre-GMP Advanced Therapies Digital & Automation Productivity Testbed

A contract/lot is awarded: Yes

five.2) Award of contract

five.2.1) Date of conclusion of the contract

26 March 2024

five.2.2) Information about tenders

Number of tenders received: 1

Number of tenders received from SMEs: 1

The contract has been awarded to a group of economic operators: No

five.2.3) Name and address of the contractor

Autolomous Ltd

20-22 Wenlock Road

London

N1 7GU

Email

info@autolomous.com

Country

United Kingdom

NUTS code
  • UKI41 - Hackney and Newham
National registration number

11810723

Internet address

https://autolomous.com/

The contractor is an SME

Yes

five.2.4) Information on value of contract/lot (excluding VAT)

Total value of the contract/lot: £350,000


Section six. Complementary information

six.4) Procedures for review

six.4.1) Review body

Catapult CT

Stevenage

Country

United Kingdom